Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bernard

Showing results (491-500 of 564) with videos related to

Pageof 57
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 23, 2004
[Value of the association of D-dimer measurement and the evaluation of clinical probability in a non-invasive diagnostic strategy of pulmonary embolism]L Palud, M Laurent, P Guéret, et al.
Ecotoxicology and Environmental Safety|October 22, 2018
Combined toxic effects and DNA damage to two plant species exposed to binary metal mixtures (Cd/Pb)C Lanier, F Bernard, S Dumez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 11, 2018
HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1Zahra Kiani, Franck P Dupuy, Julie Bruneau, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2003
The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivityWouter A P Breeman, Katy van der Wansem, Bert F Bernard, et al.
International Journal of Cancer|September 20, 2000
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapyP M van Hagen, W A Breeman, H F Bernard, et al.
Journal of Leukocyte Biology|January 31, 2019
Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCCIrene Lisovsky, Sanket Kant, Alexandra Tremblay-McLean, et al.
British Journal of Haematology|February 1, 1992
VAD or VMBCP in severe multiple myeloma. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)M Monconduit, J F Menard, J L Michaux, et al.
Iscience|October 21, 2022
MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4<sup>+</sup> T cellsNicolas Bellini, Robert Lodge, Tram N Q Pham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2002
Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapyWouter A P Breeman, Marion de Jong, Jack L Erion, et al.
Viruses|February 28, 2023
The Frequency and Function of NKG2C<sup>+</sup>CD57<sup>+</sup> Adaptive NK Cells in Cytomagalovirus Co-Infected People Living with HIV Decline with Duration of Antiretroviral TherapyKhlood Alsulami, Franck P Dupuy, Louise Gilbert, et al.
Pageof 57

Showing results (491-500 of 564) with videos related to

Sort By:
Pageof 57
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 23, 2004
[Value of the association of D-dimer measurement and the evaluation of clinical probability in a non-invasive diagnostic strategy of pulmonary embolism]L Palud, M Laurent, P Guéret, et al.
Ecotoxicology and Environmental Safety|October 22, 2018
Combined toxic effects and DNA damage to two plant species exposed to binary metal mixtures (Cd/Pb)C Lanier, F Bernard, S Dumez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 11, 2018
HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1Zahra Kiani, Franck P Dupuy, Julie Bruneau, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2003
The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivityWouter A P Breeman, Katy van der Wansem, Bert F Bernard, et al.
International Journal of Cancer|September 20, 2000
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapyP M van Hagen, W A Breeman, H F Bernard, et al.
Journal of Leukocyte Biology|January 31, 2019
Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCCIrene Lisovsky, Sanket Kant, Alexandra Tremblay-McLean, et al.
British Journal of Haematology|February 1, 1992
VAD or VMBCP in severe multiple myeloma. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)M Monconduit, J F Menard, J L Michaux, et al.
Iscience|October 21, 2022
MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4<sup>+</sup> T cellsNicolas Bellini, Robert Lodge, Tram N Q Pham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2002
Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapyWouter A P Breeman, Marion de Jong, Jack L Erion, et al.
Viruses|February 28, 2023
The Frequency and Function of NKG2C<sup>+</sup>CD57<sup>+</sup> Adaptive NK Cells in Cytomagalovirus Co-Infected People Living with HIV Decline with Duration of Antiretroviral TherapyKhlood Alsulami, Franck P Dupuy, Louise Gilbert, et al.
Pageof 57